UAS regulatory sequences drive expression of a full-length, pathogenic form of Hsap\ATXN3 (has a polyglutamine repeat of 77-80 residues) with mutations in Ubiquitin-binding site 2 (UbS2) that strongly disrupt binding to Rad23 protein (mutations are Y27E, F28E and W87E).